Therapeutic antibodies for COVID-19: is a new age of IgM, IgA and bispecific antibodies coming?
Early humoral immune responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are dominated by IgM and IgA antibodies, which greatly contribute to virus neutralization at mucosal sites. Given the essential roles of IgM and IgA in the control and elimination of SARS-CoV-2 infection,...
Saved in:
Main Authors: | Jingjing Zhang (Author), Han Zhang (Author), Litao Sun (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2022-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Diagnosis of Helicobacter pylori Infection Using ELISA for Detection of Serum IgM, IgG and IgA Antibodies
by: MH K. Ansari, et al.
Published: (2007) -
Diagnosis of Helicobacter pylori Infection Using ELISA for Detection of Serum IgM, IgG and IgA Antibodies
by: MH K. Ansari, et al.
Published: (2007) -
Detection of Toxoplasma gondii IgM and Cytomegalovirus IgM antibodies among blood donors in Mosul
by: Karam A. Al-Dabbagh
Published: (2011) -
The eIg technology to generate Ig-like bispecific antibodies
by: Lennart Kühl, et al.
Published: (2022) -
Seroprevalence of antibodies IgG/IgM anti-T. gondii in women of Coro, Venezuela
by: Saúl-García Yotsabeth, et al.
Published: (2019)